IL-6: A Marker for AML Chemo Sensitivity

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This article has no abstract
Epistemonikos ID: a5e9ac3266476af28d56f4faffd53b3f7033faf6
First added on: Apr 17, 2025